P10, the N-terminal domain of p35, protects against CDK5/p25-induced neurotoxicity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 49, 2012, Pages 20041-20046

  Zhang, Lingyan ^a   Liu, Wen ^b,c   Szumlinski, Karen K ^a   Lew, John ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Alzheimer's disease; Anti death

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; CYCLIN DEPENDENT KINASE 5; HISTONE H2AX; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; NEUROTOXIN; PEROXIREDOXIN 2; PROTEIN P10; PROTEIN P25; PROTEIN P35; REACTIVE OXYGEN METABOLITE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; DOUBLE STRANDED DNA BREAK; ENZYME INHIBITION; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIN-DEPENDENT KINASE 5; IMMUNOHISTOCHEMISTRY; MICROSCOPY, FLUORESCENCE; NERVE TISSUE PROTEINS; NEURONS; PEPTIDE FRAGMENTS; PEPTIDES; PEROXIREDOXINS; PHOSPHORYLATION; PROTEOLYSIS; RATS; REACTIVE OXYGEN SPECIES; TETRAZOLIUM SALTS; THIAZOLES;

ANIMALIA; MAMMALIA;

EID: 84870594338     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1212914109     Document Type: Article

References (48)

1. Ishiguro K, et al. (1992) Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments. J Biol Chem 267(15):10897-10901.
2. Lew J, Beaudette K, Litwin CM, Wang JH (1992) Purification and characterization of a novel proline-directed protein kinase from bovine brain. J Biol Chem 267(19):13383-13390.
3. Kobayashi S, et al. (1993) A cdc2-related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubule. FEBS Lett 335(2):171-175. (Pubitemid 23350401)
4. Lew J, Winkfein RJ, Paudel HK, Wang JH (1992) Brain proline-directed protein kinase is a neurofilament kinase which displays high sequence homology to p34cdc2. J Biol Chem 267(36):25922-25926. (Pubitemid 23013996)
5. Ishiguro K, et al. (1994) Identification of the 23 kDa subunit of tau protein kinase II as a putative activator of cdk5 in bovine brain. FEBS Lett 342(2):203-208. (Pubitemid 24115197)
6. Lew J, et al. (1994) A brain-specific activator of cyclin-dependent kinase 5. Nature 371 (6496):423-426. (Pubitemid 24302557)
7. Tsai LH, Delalle I, Caviness VS, Jr., Chae T, Harlow E (1994) p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371(6496):419-423. (Pubitemid 24302556)
8. Uchida T, et al. (1994) Precursor of cdk5 activator, the 23 kDa subunit of tau protein kinase II: Its sequence and developmental change in brain. FEBS Lett 355(1):35-40. (Pubitemid 24352098)
9. Kusakawa G, et al. (2000) Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25. J Biol Chem 275(22):17166-17172. (Pubitemid 30398964)
10. Lee MS, et al. (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405(6784):360-364.
11. Nath R, et al. (2000) Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells. Biochem Biophys Res Commun 274(1):16-21. (Pubitemid 30496750)
12. Qi Z, Huang QQ, Lee KY, Lew J, Wang JH (1995) Reconstitution of neuronal Cdc2-like kinase from bacteria-expressed Cdk5 and an active fragment of the brain-specific activator. Kinase activation in the absence of Cdk5 phosphorylation. J Biol Chem 270 (18):10847-10854.
13. Hisanaga S, Saito T (2003) The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator. Neurosignals 12(4-5):221-229. (Pubitemid 37548237)
14. Brinkkoetter PT, Pippin JW, Shankland SJ (2010) Cyclin I-Cdk5 governs survival in postmitotic cells. Cell Cycle 9(9):1729-1731.
15. Cruz JC, Tsai LH (2004) A Jekyll and Hyde kinase: Roles for Cdk5 in brain development and disease. Curr Opin Neurobiol 14(3):390-394. (Pubitemid 38759871)
16. Gupta A, Tsai LH (2003) Cyclin-dependent kinase 5 and neuronal migration in the neocortex. Neurosignals 12(4-5):173-179. (Pubitemid 37548231)
17. Dhavan R, Tsai LH (2001) A decade of CDK5. Nat Rev Mol Cell Biol 2(10):749-759. (Pubitemid 33679837)
18. Patrick GN, et al. (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402(6762):615-622. (Pubitemid 129516324)
19. Nguyen KC, Rosales JL, Barboza M, Lee KY (2002) Controversies over p25 in Alzheimer's disease. J Alzheimers Dis 4(2):123-126. (Pubitemid 34578708)
20. Cruz JC, Tsai LH (2004) Cdk5 deregulation in the pathogenesis of Alzheimer's disease. Trends Mol Med 10(9):452-458. (Pubitemid 39209212)
21. Otth C, et al. (2002) AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576. J Alzheimers Dis 4(5):417-430. (Pubitemid 35397807)
22. Lau LF, Ahlijanian MK (2003) Role of cdk5 in the pathogenesis of Alzheimer's disease. Neurosignals 12(4-5):209-214.
23. Qu D, et al. (2007) Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease. Neuron 55(1):37-52. (Pubitemid 46990825)
24. Smith PD, et al. (2003) Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci USA 100(23): 13650-13655. (Pubitemid 37444794)
25. Nguyen MD, Larivière RC, Julien JP (2001) Deregulation of Cdk5 in a mouse model of ALS: Toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30(1):135-147. (Pubitemid 32441682)
26. Peterson DW, et al. (2010) No difference in kinetics of tau or histone phosphorylation by CDK5/p25 versus CDK5/p35 in vitro. Proc Natl Acad Sci USA 107(7):2884-2889.
27. Fu X, et al. (2006) Identification of nuclear import mechanisms for the neuronal Cdk5 activator. J Biol Chem 281(51):39014-39021. (Pubitemid 46041860)
28. Asada A, et al. (2008) Myristoylation of p39 and p35 is a determinant of cytoplasmic or nuclear localization of active cyclin-dependent kinase 5 complexes. J Neurochem 106(3):1325-1336.
29. Guo Q (2006) When good Cdk5 turns bad. Sci SAGE KE 2006(5):pe5.
30. O'HareMJ, et al. (2005) Differential roles of nuclear and cytoplasmic cyclin-dependent kinase 5 in apoptotic and excitotoxic neuronal death. J Neurosci 25(39):8954-8966. (Pubitemid 41384464)
31. Smith PD, et al. (2006) Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2. J Neurosci 26(2):440-447. (Pubitemid 43237108)
32. Tian B, Yang Q, Mao Z (2009) Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death. Nat Cell Biol 11(2):211-218.
33. Maestre C, Delgado-Esteban M, Gomez-Sanchez JC, Bolaños JP, Almeida A (2008) Cdk5 phosphorylates Cdh1 and modulates cyclin B1 stability in excitotoxicity. EMBO J 27(20):2736-2745.
34. Lee JH, Kim HS, Lee SJ, Kim KT (2007) Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death. J Cell Sci 120(Pt 13):2259-2271.
35. Tarricone C, et al. (2001) Structure and regulation of the CDK5-p25(nck5a) complex. Mol Cell 8(3):657-669.
36. Amin ND, Albers W, Pant HC (2002) Cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35. J Neurosci Res 67(3):354-362. (Pubitemid 34137142)
37. Tipton KF, Singer TP (1993) Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J Neurochem 61(4):1191-1206. (Pubitemid 23285075)
38. Przedborski S, Jackson-Lewis V (1998) Mechanisms of MPTP toxicity. Mov Disord 13 (Suppl 1):35-38.
39. Hirsch EC (1999) Mechanism and consequences of nerve cell death in Parkinson's disease. J Neural Transm Suppl 56:127-137.
40. Javitch JA, Snyder SH (1984) Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP. Eur J Pharmacol 106(2):455-456. (Pubitemid 15210642)
41. Javitch JA, Uhl GR, Snyder SH (1984) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: Characterization and localization of receptor binding sites in rat and human brain. Proc Natl Acad Sci USA 81(14):4591-4595. (Pubitemid 14055938)
42. Rhee SG, Yang KS, Kang SW, Woo HA, Chang TS (2005) Controlled elimination of intracellular H(2)O(2): Regulation of peroxiredoxin, catalase, and glutathione peroxidase via post-translational modification. Antioxid Redox Signal 7(5-6):619-626. (Pubitemid 40563199)
43. Becker EB, Bonni A (2004) Cell cycle regulation of neuronal apoptosis in development and disease. Prog Neurobiol 72(1):1-25. (Pubitemid 38294359)
44. Kim D, et al. (2008) Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity. Neuron 60 (5):803-817.
45. Chew J, et al. (2010) Identification of p10 as a neurotoxic product generated from the proteolytic cleavage of the neuronal Cdk5 activator. J Cell Biochem 111(5):1359-1366.
46. Cruz JC, Tseng HC, Goldman JA, Shih H, Tsai LH (2003) Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40(3):471-483. (Pubitemid 37494698)
47. Noble W, et al. (2003) Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 38(4):555-565. (Pubitemid 36645031)
48. Zhang J, et al. (2010) Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex. J Neurosci 30(15):5219-5228.